x

Coronavirus

Portugal Will Start Administering the Johnson & Johnson Vaccine

LISBON, Portugal — Portugal will start administering the Johnson & Johnson vaccine a day after European regulators gave it the go-ahead following a blood clot concern

Portuguese Health Minister Marta Temido says the shot will speed up the goal of vaccinating those over 60 years old. But she added national authorities will study findings by European regulators to determine if any restrictions should be placed on its use for younger people.

The European Union’s drug regulatory agency said Tuesday that it found a “possible link” between Johnson & Johnson’s COVID-19 vaccine and extremely rare blood clots and that a warning should be added to the label.

Last month Portugal restricted the use of the AstraZeneca vaccine to only people over 60 after it was linked to similar cases of rare blood clots.

Portugal has received 31,200 doses from the Johnson & Johnson vaccine and more deliveries are expected.

RELATED

ATHENS – While the New Democracy government is easing health restrictions for rabid anti-vaxxers, those fully vaccinated against COVID-19 may need a fourth shot in the autumn.

Top Stories

Columnists

A pregnant woman was driving in the HOV lane near Dallas.

General News

FALMOUTH, MA – The police in Falmouth have identified the victim in an accident involving a car plunging into the ocean on February 20, NBC10 Boston reported.

General News

NEW YORK – Meropi Kyriacou, the new Principal of The Cathedral School in Manhattan, was honored as The National Herald’s Educator of the Year.

Video

SNF Dialogues: Modern Political Values, Ancient Drama

ATHENS - In today’s environment of omnipresent polarization, when even the most fundamental values of democracy are being called into question, ancient drama retains its power to catalyze reflection and discussion on political culture, SNF says.

Enter your email address to subscribe

Provide your email address to subscribe. For e.g. abc@xyz.com

You may unsubscribe at any time using the link in our newsletter.